96 related articles for article (PubMed ID: 18312219)
1. Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach.
Heidema AG; Nagelkerke N
Stat Appl Genet Mol Biol; 2008; 7(2):Article5. PubMed ID: 18312219
[TBL] [Abstract][Full Text] [Related]
2. A classification model for the Leiden proteomics competition.
Hoefsloot HC; Smit S; Smilde AK
Stat Appl Genet Mol Biol; 2008; 7(2):Article8. PubMed ID: 18312222
[TBL] [Abstract][Full Text] [Related]
3. Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest.
Datta S
Stat Appl Genet Mol Biol; 2008; 7(2):Article7. PubMed ID: 18312221
[TBL] [Abstract][Full Text] [Related]
4. Application of the random forest classification method to peaks detected from mass spectrometric proteomic profiles of cancer patients and controls.
Barrett JH; Cairns DA
Stat Appl Genet Mol Biol; 2008; 7(2):Article4. PubMed ID: 18312218
[TBL] [Abstract][Full Text] [Related]
5. Support vector machine approach to separate control and breast cancer serum samples.
Pham TV; van de Wiel MA; Jimenez CR
Stat Appl Genet Mol Biol; 2008; 7(2):Article11. PubMed ID: 18312216
[TBL] [Abstract][Full Text] [Related]
6. Empirical Bayes logistic regression.
Strimenopoulou F; Brown PJ
Stat Appl Genet Mol Biol; 2008; 7(2):Article9. PubMed ID: 18312223
[TBL] [Abstract][Full Text] [Related]
7. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
[TBL] [Abstract][Full Text] [Related]
8. Feature extraction and dimensionality reduction for mass spectrometry data.
Liu Y
Comput Biol Med; 2009 Sep; 39(9):818-23. PubMed ID: 19646687
[TBL] [Abstract][Full Text] [Related]
9. Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection.
Hong YJ; Wang XD; Shen D; Zeng S
Acta Pharmacol Sin; 2008 Oct; 29(10):1240-6. PubMed ID: 18817630
[TBL] [Abstract][Full Text] [Related]
10. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
11. A pilot study on the application of statistical classification procedures to molecular epidemiological data.
Schwender H; Zucknick M; Ickstadt K; Bolt HM;
Toxicol Lett; 2004 Jun; 151(1):291-9. PubMed ID: 15177665
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
Liu DH; Zhang LM; Feng WY
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
[No Abstract] [Full Text] [Related]
13. Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples.
van der Werff MP; Mertens B; de Noo ME; Bladergroen MR; Dalebout HC; Tollenaar RA; Deelder AM
Stat Appl Genet Mol Biol; 2008; 7(2):Article2. PubMed ID: 18241195
[TBL] [Abstract][Full Text] [Related]
14. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
15. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
16. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing breast cancer from FNAs: variable relevance in neural network and logistic regression models.
Ohno-Machado L; Bialek D
Stud Health Technol Inform; 1998; 52 Pt 1():537-40. PubMed ID: 10384515
[TBL] [Abstract][Full Text] [Related]
18. Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.
Wang QT; Li YZ; Liang YF; Hu CJ; Zhai YH; Zhao GF; Zhang J; Li N; Ni AP; Chen WM; Xu Y
Anat Rec (Hoboken); 2009 Apr; 292(4):604-10. PubMed ID: 19301277
[TBL] [Abstract][Full Text] [Related]
19. Predicting breast cancer survivability: a comparison of three data mining methods.
Delen D; Walker G; Kadam A
Artif Intell Med; 2005 Jun; 34(2):113-27. PubMed ID: 15894176
[TBL] [Abstract][Full Text] [Related]
20. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]